住院及药物转换对房颤患者口服抗凝药出院后依从性的影响
本研究利用美国商业保险索赔数据,纳入22,429例房颤口服抗凝药患者,采用准实验前后观察设计,比较住院前后6个月和12个月的比例覆盖天数。结果显示住院后依从性普遍下降,出血相关住院者额外降低3.2%,而住院后从华法林转换为直接口服抗凝药者依从性下降幅度较小3.4%。
要点
- 住院与房颤患者口服抗凝药依从性下降存在时间关联,无论住院原因。
- 出血相关住院者出院后6个月依从性额外降低3.2%。
- 住院后从华法林转换为直接口服抗凝药者依从性下降幅度减少3.4%。
核心结论
- 住院与口服抗凝药依从性下降存在时间关联,且不因住院原因而异。
- 出血相关住院者出院后依从性下降幅度更大。
- 住院后从华法林转换为直接口服抗凝药者依从性下降幅度较小。
- 需要更有效的策略改善口服抗凝药依从性,尤其在医疗过渡期。
研究设计与样本
- 准实验前后观察性研究,使用美国2009至2016年Optum商业保险医疗索赔数据库。
- 纳入22,429例房颤成人患者,随机住院发生在首次观察到口服抗凝药处方配药之后,且前后6个月内无其他入院。
- 采用比例覆盖天数评估住院前后6个月和12个月的口服抗凝药依从性。
- 采用双重差分分析比较住院前后比例覆盖天数,按住院原因分层并调整基线特征不平衡。
主要发现
- 22,429例患者以男性为主(52.4%)、白人为主(77.2%),中位年龄74岁。
- 1029例(4.5%)合格住院的原因为临床显著出血。
- 协变量调整后,无论入院诊断如何,出院后比例覆盖天数均下降(p<0.0001)。
- 6个月双重差分分析显示,出血组依从性较非出血组额外降低3.2%(p=0.0003)。
- 6个月双重差分分析显示,住院后从华法林转换为直接口服抗凝药者依从性下降幅度较其他转换者小3.4%(p=0.0342),无论住院原因。
临床怎么用
- 临床应关注房颤患者住院后口服抗凝药依从性下降,尤其在出院过渡期加强用药管理。
- 对出血相关住院患者需特别关注出院后抗凝治疗依从性。
- 住院后从华法林转换为直接口服抗凝药可能有助于减缓依从性下降。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Adherence to chronic medications remains poor in practice. There is limited evidence on how hospitalization affects post-discharge adherence to oral anticoagulants (OACs) in individuals with atrial fibrillation. The aim of this study was to examine the impact of hospitalization and medication switching on post-discharge adherence to OACs in the population with atrial fibrillation. METHODS: A quasi-experimental pre-post observational study was conducted using United States commercial insurance health care claims from the 2009 to 2016 Optum database. Adults with atrial fibrillation taking OACs who had a random hospitalization occurring after the first observed OAC prescription fill and no other admission in the preceding and following 6 months were identified. OAC adherence was estimated by the proportion of days covered within 6 and 12 months before and after hospitalization. Difference-in-difference analysis was employed to compare the pre-hospitalization and post-hospitalization proportion of days covered, stratified by reasons for hospitalization (i.e., bleeding vs non-bleeding-related reasons) and adjusting for imbalanced baseline characteristics between groups. Change in adherence when the OAC was switched at discharge was also examined. RESULTS: The 22,429 individuals who met study criteria were predominantly male (52.4%), white (77.2%), and older age (median 74 years). A clinically significant hemorrhage was the reason for 1029 (4.5%) of qualifying hospitalizations. After covariate adjustment, there was a reduction in the proportion of days covered after discharge, regardless of admission diagnosis (p<0.0001). The 6-month difference-in-difference analyses revealed that adherence was incrementally reduced by 3.2% (p=0.0003) in the bleeding group compared with the nonbleeding group, whereas switching from warfarin to a direct oral anticoagulant after hospitalization was associated with a smaller reduction by 3.4% in adherence (p=0.0342) compared with other switchers, regardless of the reason for hospitalization. The 12-month difference-in-difference analyses revealed similar results. CONCLUSIONS: Hospitalization is temporally associated with a reduction in adherence to OACs, regardless of reason for hospitalization. More effective strategies are needed to improve OAC adherence, particularly during transition of care.
引用
- Pham Nguyen TP, Chen Y, Thibault D, et al. Impact of Hospitalization and Medication Switching on Post-discharge Adherence to Oral Anticoagulants in Patients With Atrial Fibrillation. Pharmacotherapy. 2020. PMID: 32869324. doi:10.1002/phar.2457
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。